Swarandeep Singh

Delhi, DL 110029, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Human Antibody Isotypes, Subclasses, Allotypes and Fc Biology: Clinical Implications in Infectious Diseases, Autoimmunity, and Cancer.

Human Antibody Isotypes, Subclasses, Allotypes and Fc Biology: Clinical Implications in Infectious Diseases, Autoimmunity, and Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 15, 2026

Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response.

Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response.

Journal: Journal of virology
Published: April 21, 2026

Viral Vaccine Adjuvant Strategies for Shaping Durable Immunity Across the Human Lifespan.

Viral Vaccine Adjuvant Strategies for Shaping Durable Immunity Across the Human Lifespan.

Journal: Vaccines
Published: April 17, 2026

The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple Platforms.

The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple Platforms.

Journal: Vaccines
Published: December 06, 2024

Design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platforms.

Design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platforms.

Journal: bioRxiv : the preprint server for biology
Published: September 30, 2024

Erratum: Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody.

Erratum: Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody.

Journal: iScience
Published: October 19, 2023

Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody.

Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody.

Journal: iScience
Published: February 13, 2023

Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma.

Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma.

Journal: PLoS pathogens
Published: August 08, 2021

The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41.

The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41.

Journal: International immunopharmacology
Published: July 26, 2021

Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus.

Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus.

Journal: International immunopharmacology
Published: May 12, 2021

Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children.

Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children.

Journal: The Journal of general virology
Published: September 11, 2020
Showing 1-11 of 11

Last Updated: 09/26/2026